Prestige Consumer Healthcare
PBH
#3908
Rank
NZ$5.28 B
Marketcap
NZ$107.35
Share price
-0.61%
Change (1 day)
-23.47%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): NZ$7.02

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is NZ$7.04. In 2024 the company made an earnings per share (EPS) of NZ$7.45 an increase over its 2023 EPS that were of NZ-$2.79.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$7.02-5.78%
2024NZ$7.45-367.08%
2023NZ-$2.79-138.33%
2022NZ$7.2811.7%
2021NZ$6.5213.6%
2020NZ$5.74-651.67%
2019NZ-$1.04-148.78%
2018NZ$2.13-83.29%
2017NZ$12.76437.23%
2016NZ$2.37-34.13%
2015NZ$3.6052.94%
2014NZ$2.36-8.11%
2013NZ$2.56
2011NZ$1.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
GlaxoSmithKline
GSK
NZ$6.23-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$2.98-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Rite Aid
RAD
NZ-$51.33-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.09 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$2.11-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$12.76 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Procter & Gamble
PG
NZ$12.18 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$0.69-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$11.11 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.96 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA